Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.
Psychedelics are a “game changer” in depression care, according to William Blair, but the complicated treatment regimens mean ...
Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.
Depression-related fatigue is caused by cellular "overworking" at rest and a failure to produce energy under stress.
Detailed price information for SPDR S&P Midcap International (MDD-A) from The Globe and Mail including charting and trades.
Detailed price information for SPDR S&P Midcap International (MDD-A) from The Globe and Mail including charting and trades.
This study presents valuable findings for identifying biotypes of depression patients using white matter measures, which are under-utilised and under-appreciated in current biological and ...
A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...
TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology company, today announced financial results for the fourth quarter and full ...
Researchers found that the cells of young adults with depression overproduce energy while resting but struggle to respond to ...
Anxiety disorders are common. However, anxiety can also be a symptom of a general medical disorder or a side effect of a medication. Those cases must be identified promptly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results